Whole body and hematopoietic ADAM8 deficiency does not influence advanced atherosclerotic lesion development, despite its association with human plaque progression

Kosta Theodorou, Emiel P. C. van der Vorst, Marion J. Gijbels, Ine M. J. Wolfs, Mike Jeurissen, Thomas L. Theelen, Judith C. Sluimer, Erwin Wijnands, Jack P. Cleutjens, Yu Li, Yvonne Jansen, Christian Weber, Andreas Ludwig, Jacob F. Bentzon, Joerg W. Bartsch, Erik A. L. Biessen, Marjo M. P. C. Donners*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Article number11670
Number of pages11
JournalScientific Reports
Volume7
DOIs
Publication statusPublished - 15 Sep 2017

Keywords

  • METALLOPROTEASE-DISINTEGRIN ADAM8
  • TUMOR-NECROSIS-FACTOR
  • MYOCARDIAL-INFARCTION
  • TNF-ALPHA
  • EXPRESSION ANALYSIS
  • PERIPHERAL-BLOOD
  • DENDRITIC CELLS
  • TRANSGENIC MICE
  • IMMUNE-SYSTEM
  • MACROPHAGES

Cite this